Intuitive Surgical, Inc. (NASDAQ:ISRG) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have been assigned an average rating of “Moderate Buy” from the seventeen research firms that are covering the company, MarketBeat reports. Four equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $396.17.

ISRG has been the subject of a number of research analyst reports. Royal Bank of Canada lifted their price target on Intuitive Surgical from $400.00 to $432.00 and gave the company an “outperform” rating in a research report on Wednesday, January 24th. Raymond James upped their target price on Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a research note on Thursday, January 25th. Barclays boosted their price objective on Intuitive Surgical from $385.00 to $430.00 and gave the company an “overweight” rating in a research report on Thursday, January 25th. Stifel Nicolaus upped their target price on Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a report on Monday, April 8th. Finally, Truist Financial upped their target price on Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a report on Wednesday, January 24th.

Insiders Place Their Bets

In other Intuitive Surgical news, VP Marshall Mohr sold 108,790 shares of the stock in a transaction on Wednesday, February 28th. The stock was sold at an average price of $385.08, for a total value of $41,892,853.20. Following the completion of the transaction, the vice president now owns 26,877 shares in the company, valued at $10,349,795.16. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In related news, Director Alan J. Levy sold 2,000 shares of the stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total transaction of $741,400.00. Following the sale, the director now directly owns 25,319 shares of the company’s stock, valued at $9,385,753.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, VP Marshall Mohr sold 108,790 shares of the stock in a transaction on Wednesday, February 28th. The shares were sold at an average price of $385.08, for a total value of $41,892,853.20. Following the sale, the vice president now directly owns 26,877 shares in the company, valued at $10,349,795.16. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 249,418 shares of company stock worth $96,300,959. 0.90% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Intuitive Surgical

Institutional investors have recently modified their holdings of the business. OFI Invest Asset Management bought a new position in Intuitive Surgical in the third quarter valued at about $25,000. Baystate Wealth Management LLC lifted its holdings in Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 45 shares during the period. MCF Advisors LLC lifted its holdings in Intuitive Surgical by 108.1% in the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after acquiring an additional 40 shares during the period. Headinvest LLC bought a new position in Intuitive Surgical in the third quarter valued at about $28,000. Finally, Able Wealth Management LLC bought a new position in Intuitive Surgical in the fourth quarter valued at about $28,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Up 0.6 %

Shares of NASDAQ ISRG opened at $375.33 on Friday. The company has a market cap of $133.13 billion, a P/E ratio of 67.75, a P/E/G ratio of 4.84 and a beta of 1.36. The business has a 50-day simple moving average of $386.19 and a two-hundred day simple moving average of $345.95. Intuitive Surgical has a 52 week low of $254.85 and a 52 week high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. The firm had revenue of $1.89 billion during the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The company’s revenue for the quarter was up 11.5% on a year-over-year basis. During the same quarter last year, the company posted $1.00 EPS. Equities research analysts anticipate that Intuitive Surgical will post 4.8 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.